NeuroSense Therapeutics Ltd. Share-based Payment Arrangement, Expensed and Capitalized, Amount
NeuroSense Therapeutics Ltd. (NRSN) had Share-based Payment Arrangement, Expensed and Capitalized, Amount of $23.00 thousand as of 2022-01-11, per its 6-K filed 2024-06-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2024-06-17
- 2022-01-11: Share-based Payment Arrangement, Expensed and Capitalized, Amount $23.00K.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount |
|---|---|
| 2022-01-11 | $23.00K 6-K · filed 2024-06-17 |